Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04341363 · ClinicalTrials.gov registry record · NA
Follicular Revival in Androgenic Alopecia: Evaluating Use of Micro-needling
A NA study of Androgenic Alopecia, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT04341363 is a NA study of Androgenic Alopecia that has completed, run by Yale University. The registered enrollment target is 8 participants, below the 75-participant average among 4 other Androgenic Alopecia trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04341363, a NA study of Androgenic Alopecia, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
The intent of this study is to evaluate the efficacy of microneedling through use of a professional tattoo machine in hair regrowth in patients with androgenic alopecia (AGA) over up to 6 treatments (6 months).
Conditions Studied
Interventions
- DEVICE Tattoo machine
Study Locations (1)
Connecticut
- Yale University - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2021-04-09 |
| Est. Completion | 2022-05-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04341363
The ClinicalTrials.gov registry entry for NCT04341363 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 75-participant average among 4 other Androgenic Alopecia trials with a reported enrollment target (89% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Androgenic Alopecia appearing as the primary indexed condition, and to 1 intervention - of which Tattoo machine is the first listed.
NCT04341363 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT04341363 about?
NCT04341363 is a clinical study titled "Follicular Revival in Androgenic Alopecia: Evaluating Use of Micro-needling". The intent of this study is to evaluate the efficacy of microneedling through use of a professional tattoo machine in hair regrowth in patients with androgenic alopecia (AGA) over up to 6 treatments (6 months).
What is the current status of trial NCT04341363?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2021-04-09. Estimated completion is 2022-05-02.
What conditions does trial NCT04341363 study?
This clinical trial studies the following conditions: Androgenic Alopecia.
What interventions are being tested in trial NCT04341363?
The interventions under investigation include: Tattoo machine (DEVICE).
Who is sponsoring clinical trial NCT04341363?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04341363 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Androgenic Alopecia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Computer-Assisted Hair Restoration Study Using ARTAS System
RECRUITING · NA
-
Autologous Hair Follicle Secretome for Androgenic Alopecia (Single Site)
RECRUITING · NA
-
Keravive by Hydrafacial for Scalp Health and Enhanced Hair Quality
COMPLETED · NA
-
A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Female Subjects With Hair Loss
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.